Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.16 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:07 PM EDT

Drugs Made In America Acquisition II Corp. (DMII) Operating Income (2025 - 2026)

Drugs Made In America Acquisition's (DMII) quarterly Operating Income came in at -$112227.0 in Q2 2026, up 52.34% quarter-over-quarter from -$235472.0 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Drugs Made In America Acquisition II Corp. (DMII) Operating Income (2025 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Operating Income for 2 consecutive years, with -$112227.0 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -112,227.00
Dec 31, 2025 -235,472.00
Sep 30, 2025 -155,513.00